Category Specific RSS

Categories: News

HR tech booming as Xref automated reference tech sales surge

Gone may be the days of awkward reference checking over the phone if the record sales by HR tech company Xref (ASX: XF1) are a sign of future recruiting practices, especially once hiring resumes after coronavirus protocols are lifted.

Despite the global economic downturn brought upon by the coronavirus pandemic which has led to unemployment spikes around the world, Xref reported $970k in receipts for the month of April, a substantial 37% increase on the corresponding month in 2019. 

Included in the month’s sales of their reference automation technology were the acquisition of sizable new clients in Australia, the United States, Norway, United Kingdom and New Zealand, highlighting Xref’s global appeal. 

“We are a technology platform built to withstand turbulence and adapt to all market conditions, meaning we are able to continue to deliver results in a pressured global environment,” said Executive Director, Tim Griffiths.  

“During the COVID-19 pandemic, we have seen our systems scale with bulk uploads for the recruitment of support workers, new clients automatically onboarded, custom questionnaires designed with speed and ease using our Template Builder tool and integrations switched on in a heartbeat to aid workflows. 

“We have done this in multiple languages, across time zones and regional data centres.” 

Having previously focused on organisations within ‘trust’ economies such as health, government, non-for-profit and education, these sectors had mostly been deemed ‘essential services’ during COVID-19 which saw less impact on hiring practices than other sectors. 

Using XRef’s platform, hiring managers are able to integrate Xref into applicant tracking systems to automate reference checking, submit background check information and provide insights into candidates using Xref’s algorithm. 

Although sales are up in 2020, the company reported a net loss of $1.94 million for the Quarter ending 31 March 2020 but has recently reduced the company headcount from 98 to 61 people and qualified for government subsidy packages which will be reflected in the Q4 cash flow.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards

A major Australian research initiative is set to push forward global understanding of brain injury,…

11 hours ago

Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion

Following a successful FY25 which saw a boost in gross profit after launching its refurbished…

1 week ago

Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program

Pivotal Metals (ASX:PVT) has locked in $5.4 million in fresh funding to accelerate exploration across…

2 weeks ago

Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise

Biotech company Biotron Limited (ASX:BIT) has announced a bold step into the anaesthetics sector, acquiring…

3 weeks ago

DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment

DroneShield (ASX:DRO) is expanding its Australian footprint with a $13 million investment to establish a…

1 month ago

Stakk Secures T-Mobile Contract to Power Super App Expansion

Australian fintech Stakk (ASX:SKK) has signed a three-year agreement with U.S. telecommunications giant T-Mobile USA,…

1 month ago